Robert Ballotti

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cell death and differentiation

Oncoimmunology

EMBO molecular medicine

INSERM

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Jan 01 2007

France

Head, team1 :: C3M, INSERM U1065

Publications

Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Sarah Proteau, Imène Krossa, Chrystel Husser, Maxime Guéguinou, Federica Sella, Karine Bille, Marie Irondelle, Mélanie Dalmasso, Thibault Barouillet, Yann Cheli, Céline Pisibon, Nicole Arrighi, Sacha Nahon-Estève, Arnaud Martel, Lauris Gastaud, Sandra Lassalle, Olivier Mignen, Patrick Brest, Nathalie M Mazure, Frédéric Bost, Stéphanie Baillif, Solange Landreville, Simon Turcotte, Dan Hasson, Saul Carcamo, Christophe Vandier, Emily Bernstein, Laurent Yvan-Charvet, Mitchell Paul Levesque, Robert Ballotti, Corine Bertolotto, Thomas Strub
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. EMBO molecular medicine (2023)
Nadia Habel, Najla El-Hachem, Frédéric Soysouvanh, Hanene Hadhiri-Bzioueche, Serena Giuliano, Sophie Nguyen, Pavel Horák, Anne-Sophie Gay, Delphine Debayle, Nicolas Nottet, Guillaume Emmanuel Beranger, Brigitte Bressac-de Paillerets, Corine Bertolotto, Robert Ballotti
FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. Cell death and differentiation 28 (6) (2021)
Charlotte Pandiani, Thomas Strub, Nicolas Nottet, Yann Cheli, Giovanni Gambi, Karine Bille, Chrystel Husser, Mélanie Dalmasso, Guillaume Emmanuel Beranger, Sandra Lassalle, Virginie Magnone, Florence Pédeutour, Marie Irondelle, Célia Maschi, Sacha Nahon-Estève, Arnaud Martel, Jean-Pierre Caujolle, Paul Hofman, Kévin LeBrigand, Irwin Davidson, Stéphanie Baillif, Pascal Barbry, Robert Ballotti, Corine Bertolotto
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell death and differentiation 28 (6) (2021)
Nelly Durand, Méliné Simsir, Laurie Signetti, Fabien Labbal, Robert Ballotti, Isabelle Mus-Veteau
Methiothepin Increases Chemotherapy Efficacy against Resistant Melanoma Cells. Molecules (Basel, Switzerland) 26 (7) (2021)
Emilie Jaune, Elisa Cavazza, Cyril Ronco, Oleksandr Grytsai, Patricia Abbe, Nedra Tekaya, Marwa Zerhouni, Guillaume Emmanuel Beranger, Lisa Kaminski, Frédéric Bost, Maeva Gesson, Meri Tulic, Paul Hofman, Robert Ballotti, Thierry Passeron, Thomas Botton, Rachid Benhida, Stéphane Rocchi
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies. Cell death & disease 12 (1) (2021)
Nausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, Clémence Granier, Vincent Moutardier, Caroline Gaudy-Marqueste, Nadia Habel, Marion Mandavit, Bernard Guillot, Christine Pasero, Eric Tartour, Robert Ballotti, Jean-Jacques Grob, Daniel Olive
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. Oncoimmunology 8 (12) (2019)

Robert Ballotti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Ballotti